In sum, despite some suggestive positive associations of sex hormones with
breast density among young women, evidence is sparse necessitating further study.
Few studies have examined associations between sex hormones and
breast density among young women.
Not exact matches
Disparities in the level of awareness and knowledge of
breast density exist
among U.S. women, according to the results of a Mayo Clinic study published in the Journal of Clinical Oncology.
When researchers examined the survey results for race and ethnicity, they found increased
breast density awareness
among white, non-Hispanic women relative to minority women.
The study, «
Breast Density Does Not Impact the Ability of Videssa
Breast to Detect
Breast Cancer in Women Under Age 50» evaluated the performance of Videssa
Breast among 545 women, ages 25 to 50, with abnormal or difficult - to - interpret imaging (BI-RADS 3 and 4).
Potential cardioprotection was based on generally supportive data on lipid levels in intermediate outcome clinical trials, trials in nonhuman primates, and a large body of observational studies suggesting a 40 % to 50 % reduction in risk
among users of either estrogen alone or, less frequently, combined estrogen and progestin.2 - 5 Hip fracture was designated as a secondary outcome, supported by observational data as well as clinical trials showing benefit for bone mineral
density.6, 7 Invasive
breast cancer was designated as a primary adverse outcome based on observational data.3, 8 Additional clinical outcomes chosen as secondary outcomes that may plausibly be affected by hormone therapy include other cardiovascular diseases; endometrial, colorectal, and other cancers; and other fractures.3, 6,9